Follow the Immunovia AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Immunovia AB (publ) has logged 1 public disclosures. The latest transaction was disclosed on 3 June 2025 (Purchase). Among the most active insiders: Jeffrey Borcherding. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Immunovia AB (publ) es una empresa sueca centrada en el desarrollo de pruebas de diagnóstico para el cáncer, haciendo hincapié en la detección temprana de la enfermedad. Cotiza en la Bolsa de Estocolmo (XSTO).